| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |